Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic adenosine monophosphate (cAMP) is a cyclic nucleotide derived from ATP that acts as a crucial second messenger in many cellular signaling pathways. It is not itself a receptor or enzyme but rather an intracellular signal that mediates the effects of various hormones and neurotransmitters that cannot cross the cell membrane. cAMP is synthesized from ATP by the enzyme adenylate cyclase, which is activated by G protein-coupled receptors upon ligand binding. Once formed, cAMP activates protein kinase A (PKA) and other effectors such as Epac proteins and certain ion channels. Through these interactions, cAMP regulates diverse physiological processes including metabolism, gene transcription via CREB phosphorylation, cell growth and differentiation, hormone secretion, and neuronal signaling. In bacteria like E. coli it also plays regulatory roles in operon control systems such as the lac operon[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic adenosine monophosphate (cAMP).